September 2, 2015

Par Pharmaceutical on Wednesday announced that it has begun shipping its generic version of AbbVie’s AnroGel (testosterone gel 1%) in 2.5-g and 5-g foil packets.

September 1, 2015

PrescribeMedicare is meant to serve as a tool for patients in 2016 when open enrollment for plan choices begins.

August 31, 2015

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.

August 28, 2015

Mylan will now move forward with its plans to tender a formal offer directly to Perrigo’s shareholders. 

August 27, 2015

Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths. 

August 26, 2015

Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.

August 25, 2015
According to GlobalData’s report, the market is set to grow from $29.4 billion in 2014 to $47.9 billion by 2020, which represents a compound annual growth rate of 8.5%.
August 24, 2015

Camber Pharmaceuticals last week announced its introduction of its entecavir tablet in 0.5- and 1-mg dosage strengths.

August 23, 2015

IMS Health’s Doug Long gave an overview of the present state of the U.S. pharmaceutical market and where it might be headed in the coming months and years at NACDS Total Store Expo on Sunday.

August 19, 2015

The company is one of the first to launch a generic version of the discontinued Abilify Oral Solution used to treat depression, bipolar disorder and schizophrenia. 

August 19, 2015

Levy will provide key insights on the changing healthcare industry to advance the board's mission of helping consumers make more informed healthcare decisions.

August 18, 2015

Aurobindo Pharma Limited announced Tuesday that it had received approval from the Food and Drug Administration for its over-the-counter cetirizine hydrochloride in 5- and 10-mg dosage strengths.

August 14, 2015

Mylan announced will continue to urge its shareholders to vote in favor of its proposed acquisition of Perrigo despite Institutional Shareholder Services’ recommendation against the deal in a recent report.

August 14, 2015

The research project will provide pharmacogenomics services in community pharmacies including collection of DNA samples, interpretation of patient results, counseling and collaboration with prescribers. 

August 12, 2015

Dr. Reddy’s Laboratories has announced the launch and FDA approval of its pramipexole dihydrochloride extended release tablets.

August 12, 2015

Testing on an edible on-dose authentication technology developed by TruTag Technologies is showing promising results for its use in combatting counterfeit drugs. 

August 12, 2015

Verde Technologies has announced a pilot program for its Deterra Drug Deactivation System that will see the company partner with the Delaware Prescription Action Committee (PDAC) and the Delaware Pharmacists Societyt to combat prescription drug abuse.

August 11, 2015

The medication synchronization service allows patients to pick up all their medication in a monthly pharmacy visit and manage their prescriptions online. 

August 11, 2015

Three years after it launched its EpiPen4ASchools program, Mylan announced this week that it would continue through the 2015-2016 school year.

August 10, 2015

According to the Substance Abuse Mental Health Services Administration, more than 24.5 million people age 12 or older in the U.S. (9.4% of the population) live with substance use disorders.

August 10, 2015

The Food and Drug Administration approved Mylan's Lidocaine Patch 5%, a generic version of Endo Pharmaceutical's Lidoderm.

August 10, 2015

The company’s memantine hydrochloride tablets, available in 5- and 10-mg dosage strengths, are meant to treat dementia associated with Alzheimer’s disease.

August 6, 2015

Aurobindo Pharma Limited on Tuesday received approval from the Food and Drug Administration for its alprazolam tablets, a generic version of Xanax. 

August 6, 2015

Mylan on Wednesday announced the U.S. launch of its generic version of Nexium (esomeprazole magnesium delayed-release capsules) in 20- and 40-mg dosage strengths.